2004TherapyRequires access

Pharmacotherapy of constipation in children

Dinesh S. Pashankar, Vasundhara Tolia

Open publisher page 3 citations

Abstract

Constipation is a common problem in children. It is also a long-term problem persisting for many years, and beyond adolescence in about a third of children. Approximately 95% of childhood constipation is functional in nature without any obvious cause. Treatment of functional constipation in children requires a well-designed plan and a 'team approach' involving the child, parents, and a health-care provider. Treatment involves education of the family about constipation and encopresis, fecal disimpaction, and long-term maintenance therapy of laxatives and behavioral modification. Laxatives such as magnesium hydroxide (Milk of magnesia®, Philips) lactulose, and mineral oil have been used in children for a long time. Recently a new laxative, polyethyleneglycol 3350 has been used successfully in children with constipation and encopresis. New prokinetic agents have been tried in adults with constipation and may be available for children in the future.

About this research paper

What this paper is about

Constipation is a common problem in children. It is also a long-term problem persisting for many years, and beyond adolescence in about a third of children. Approximately 95% of childhood constipation is functional in nature without any obvious cause. Treatment of functional constipation in children requires a well-designed plan and a 'team approach' involving the child, parents, and a health-care provider. Treatment involves education of the family about constipation and encopresis, fecal disimpaction, and long-term maintenance therapy of laxatives and behavioral modification. Laxatives such as magnesium hydroxide (Milk of magnesia®, Philips) lactulose, and mineral oil have been used in children for a long time. Recently a new laxative, polyethyleneglycol 3350 has been used successfully in children with constipation and encopresis. New prokinetic agents have been tried in adults with constipation and may be available for children in the future.

Why it matters

OpenAlex reports 3 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Constipation is a common problem in children. It is also a long-term problem persisting for many years, and beyond adolescence in about a third of children. Approximately 95% of childhood constipation is functional in nature without any obvious cause. Treatment of functional constipation in children requires a well-designed plan and a 'team approach' involving the child, parents, and a health-care provider. Treatment involves education of the family about constipation and encopresis, fecal disimpaction, and long-term maintenance therapy of laxatives and behavioral modification. Laxatives such as magnesium hydroxide (Milk of magnesia®, Philips) lactulose, and mineral oil have been used in children for a long time. Recently a new laxative, polyethyleneglycol 3350 has been used successfully in children with constipation and encopresis. New prokinetic agents have been tried in adults with constipation and may be available for children in the future.

Key concepts: Medicine, Pharmacotherapy, Constipation, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Pharmacotherapy of constipation in children — Research Paper | ScholarLens